TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $120,648 | +520.2% | 38,180 | +29.7% | 0.00% | – |
Q2 2023 | $19,454 | -82.2% | 29,431 | -78.5% | 0.00% | – |
Q1 2023 | $109,190 | -4.1% | 137,001 | +172.0% | 0.00% | – |
Q4 2022 | $113,850 | -15.0% | 50,376 | -27.5% | 0.00% | – |
Q3 2022 | $134,000 | -45.5% | 69,505 | +5.2% | 0.00% | – |
Q2 2022 | $246,000 | -47.1% | 66,043 | -7.4% | 0.00% | – |
Q1 2022 | $465,000 | -35.2% | 71,358 | +15.8% | 0.00% | – |
Q4 2021 | $718,000 | +18.1% | 61,646 | +88.7% | 0.00% | – |
Q3 2021 | $608,000 | +17.6% | 32,677 | +34.0% | 0.00% | – |
Q2 2021 | $517,000 | +71.8% | 24,379 | +64.1% | 0.00% | – |
Q1 2021 | $301,000 | +73.0% | 14,855 | +126.6% | 0.00% | – |
Q4 2020 | $174,000 | – | 6,556 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |